|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 192 for Tnfrsf11b

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.046s

Categories

Category: Publication
« show all
Type Details Score
Publication
32905775 | J:300921
First Author: Cawley KM
Year: 2020
Journal: Cell Rep
Title: Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption.
Volume: 32
Issue: 10
Pages: 108052
•
•
•
•
•
Publication
9108485 | J:39641
First Author: Simonet WS
Year: 1997
Journal: Cell
Title: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Volume: 89
Issue: 2
Pages: 309-19
•
•
•
•
•
Publication
9714833 | J:49549
First Author: Mizuno A
Year: 1998
Journal: Gene
Title: Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis.
Volume: 215
Issue: 2
Pages: 339-43
•
•
•
•
•
Publication
9573043 | J:47602
First Author: Bucay N
Year: 1998
Journal: Genes Dev
Title: osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Volume: 12
Issue: 9
Pages: 1260-8
•
•
•
•
•
Publication
18337202 | J:136865
First Author: Liu J
Year: 2008
Journal: Bone
Title: Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Volume: 42
Issue: 5
Pages: 950-9
•
•
•
•
•
Publication
28319142 | J:247220
First Author: Liu J
Year: 2017
Journal: PLoS One
Title: MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification.
Volume: 12
Issue: 3
Pages: e0174138
•
•
•
•
•
Publication
26018435 | J:316487
First Author: Bolon B
Year: 2015
Journal: Vet Pathol
Title: Generalized Degenerative Joint Disease in Osteoprotegerin (Opg) Null Mutant Mice.
Volume: 52
Issue: 5
Pages: 873-82
•
•
•
•
•
Publication
9647741 | J:48325
First Author: Mizuno A
Year: 1998
Journal: Biochem Biophys Res Commun
Title: Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Volume: 247
Issue: 3
Pages: 610-5
•
•
•
•
•
Publication
16564235 | J:111153
First Author: Kanzaki S
Year: 2006
Journal: Bone
Title: Resorption of auditory ossicles and hearing loss in mice lacking osteoprotegerin.
Volume: 39
Issue: 2
Pages: 414-9
•
•
•
•
•
Publication
23291450 | J:194767
First Author: Koide M
Year: 2013
Journal: Endocrinology
Title: Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice.
Volume: 154
Issue: 2
Pages: 773-82
•
•
•
•
•
Publication
28937990 | J:250445
First Author: Ozaki Y
Year: 2017
Journal: PLoS One
Title: Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
Volume: 12
Issue: 9
Pages: e0184904
•
•
•
•
•
Publication
11920384 | J:75833
First Author: Oshiro T
Year: 2002
Journal: Anat Rec
Title: Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice.
Volume: 266
Issue: 4
Pages: 218-25
•
•
•
•
•
Publication
10965921 | J:108809
First Author: Udagawa N
Year: 2000
Journal: Endocrinology
Title: Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Volume: 141
Issue: 9
Pages: 3478-84
•
•
•
•
•
Publication
16467704 | J:117756
First Author: Zehnder AF
Year: 2006
Journal: Laryngoscope
Title: Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss.
Volume: 116
Issue: 2
Pages: 201-6
•
•
•
•
•
Publication
36718875 | J:334446
First Author: Karasaki K
Year: 2023
Journal: J Am Heart Assoc
Title: Angiotensin II Type 1 Receptor Blocker Prevents Abdominal Aortic Aneurysm Progression in Osteoprotegerin-Deficient Mice via Upregulation of Angiotensin (1-7).
Volume: 12
Issue: 3
Pages: e027589
•
•
•
•
•
Publication
17615383 | J:134902
First Author: Orita Y
Year: 2007
Journal: Arterioscler Thromb Vasc Biol
Title: Role of osteoprotegerin in arterial calcification: development of new animal model.
Volume: 27
Issue: 9
Pages: 2058-64
•
•
•
•
•
Publication
31958462 | J:283535
 
First Author: He Y
Year: 2020
Journal: J Mol Cell Cardiol
Title: Osteoprotegerin promotes intimal hyperplasia and contributes to in-stent restenosis: Role of an αVβ3/FAK dependent YAP pathway.
Volume: 139
Pages: 1-13
•
•
•
•
•
Publication
31932605 | J:283743
First Author: Kimura S
Year: 2020
Journal: Nat Commun
Title: Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity.
Volume: 11
Issue: 1
Pages: 234
•
•
•
•
•
Publication
27764222 | J:254882
First Author: Kamata R
Year: 2016
Journal: PLoS One
Title: EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4.
Volume: 11
Issue: 10
Pages: e0165132
•
•
•
•
•
Publication
11160187 | J:67105
First Author: Yun TJ
Year: 2001
Journal: J Immunol
Title: Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function.
Volume: 166
Issue: 3
Pages: 1482-91
•
•
•
•
•
Publication
31943048 | J:288257
First Author: Hamoudi D
Year: 2020
Journal: Hum Mol Genet
Title: Muscle weakness and selective muscle atrophy in osteoprotegerin-deficient mice.
Volume: 29
Issue: 3
Pages: 483-494
•
•
•
•
•
Publication
35463988 | J:325592
 
First Author: Mota RF
Year: 2022
Journal: Biomed Res Int
Title: RANKL Impairs the TLR4 Pathway by Increasing TRAF6 and RANK Interaction in Macrophages.
Volume: 2022
Pages: 7740079
•
•
•
•
•
Publication
12506018 | J:82928
First Author: Chagraoui H
Year: 2003
Journal: Blood
Title: Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO.
Volume: 101
Issue: 8
Pages: 2983-9
•
•
•
•
•
Publication
26094891 | J:226113
First Author: Kondegowda NG
Year: 2015
Journal: Cell Metab
Title: Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway.
Volume: 22
Issue: 1
Pages: 77-85
•
•
•
•
•
Publication
- | J:303660
First Author: Xu Y
Year: 2007
Journal: Progress in Biochemistry and Biophysics
Title: High-bone-turnover Osteoporosis and Aortic calcification in Opg knockout mice.
Volume: 34
Issue: 3
Pages: 260-266
•
•
•
•
•
Publication
36909232 | J:334978
 
First Author: Zhang M
Year: 2023
Journal: Front Physiol
Title: Delayed denervation-induced muscle atrophy in Opg knockout mice.
Volume: 14
Pages: 1127474
•
•
•
•
•
Publication
29644561 | J:309769
First Author: Wang Y
Year: 2018
Journal: J Mol Histol
Title: Osteoprotegerin deficiency causes morphological and quantitative damage in epithelial rests of Malassez.
Volume: 49
Issue: 3
Pages: 329-338
•
•
•
•
•
Publication
22551876 | J:186190
First Author: Zheng D
Year: 2012
Journal: Bone
Title: The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice.
Volume: 51
Issue: 1
Pages: 85-92
•
•
•
•
•
Publication
20963556 | J:303658
First Author: Yan MZ
Year: 2010
Journal: Endocrine
Title: Raloxifene inhibits bone loss and improves bone strength through an Opg-independent mechanism.
Volume: 37
Issue: 1
Pages: 55-61
•
•
•
•
•
Publication
38034017 | J:343232
 
First Author: Xue C
Year: 2023
Journal: Front Endocrinol (Lausanne)
Title: Aconine attenuates osteoclast-mediated bone resorption and ferroptosis to improve osteoporosis via inhibiting NF-κB signaling.
Volume: 14
Pages: 1234563
•
•
•
•
•
Publication
31318102 | J:303633
First Author: Zhao D
Year: 2020
Journal: J Cell Biochem
Title: Oleanolic acid exerts inhibitory effects on the late stage of osteoclastogenesis and prevents bone loss in osteoprotegerin knockout mice.
Volume: 121
Issue: 1
Pages: 152-164
•
•
•
•
•
Publication
22664871 | J:320060
First Author: Luan X
Year: 2012
Journal: J Immunol
Title: Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin.
Volume: 189
Issue: 1
Pages: 245-52
•
•
•
•
•
Publication
9168977 | J:314096
First Author: Tsuda E
Year: 1997
Journal: Biochem Biophys Res Commun
Title: Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.
Volume: 234
Issue: 1
Pages: 137-42
•
•
•
•
•
Publication
14764723 | J:88040
First Author: Suda K
Year: 2004
Journal: J Immunol
Title: Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.
Volume: 172
Issue: 4
Pages: 2504-10
•
•
•
•
•
Publication
16750437 | J:114079
First Author: Shin HH
Year: 2006
Journal: Bone
Title: Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells.
Volume: 39
Issue: 4
Pages: 716-23
•
•
•
•
•
Publication
16995817 | J:128104
First Author: Baldock PA
Year: 2006
Journal: J Bone Miner Res
Title: Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast.
Volume: 21
Issue: 10
Pages: 1618-26
•
•
•
•
•
Publication
23762316 | J:203198
First Author: Weiss RM
Year: 2013
Journal: PLoS One
Title: Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice.
Volume: 8
Issue: 6
Pages: e65201
•
•
•
•
•
Publication
26329493 | J:251042
 
First Author: Wang B
Year: 2015
Journal: Sci Rep
Title: Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone.
Volume: 5
Pages: 13667
•
•
•
•
•
Publication
30254073 | J:340647
First Author: Xiao Y
Year: 2018
Journal: J Biol Chem
Title: Dimerization interface of osteoprotegerin revealed by hydrogen-deuterium exchange mass spectrometry.
Volume: 293
Issue: 45
Pages: 17523-17535
•
•
•
•
•
Publication
31292134 | J:279969
First Author: Zhang C
Year: 2019
Journal: Diabetes
Title: Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
Volume: 68
Issue: 10
Pages: 1902-1914
•
•
•
•
•
Publication
36823220 | J:334805
First Author: Wu S
Year: 2023
Journal: Sci Rep
Title: Osteoprotegerin deficiency aggravates methionine-choline-deficient diet-induced nonalcoholic steatohepatitis in mice.
Volume: 13
Issue: 1
Pages: 3194
•
•
•
•
•
Publication
19641036 | J:153427
First Author: Chino T
Year: 2009
Journal: J Leukoc Biol
Title: Regulation of dendritic cell survival and cytokine production by osteoprotegerin.
Volume: 86
Issue: 4
Pages: 933-40
•
•
•
•
•
Publication
10952716 | J:64174
First Author: Min H
Year: 2000
Journal: J Exp Med
Title: Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis.
Volume: 192
Issue: 4
Pages: 463-74
•
•
•
•
•
Publication
28543818 | J:274935
First Author: Koide M
Year: 2017
Journal: J Bone Miner Res
Title: Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts.
Volume: 32
Issue: 10
Pages: 2074-2086
•
•
•
•
•
Publication
28840938 | J:337659
First Author: McGee-Lawrence ME
Year: 2018
Journal: J Cell Physiol
Title: Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin sensitivity.
Volume: 233
Issue: 4
Pages: 2671-2680
•
•
•
•
•
Publication
26751951 | J:269165
First Author: Kuroda Y
Year: 2016
Journal: PLoS One
Title: Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion.
Volume: 11
Issue: 1
Pages: e0146544
•
•
•
•
•
Publication
12446599 | J:80503
First Author: Yamashita T
Year: 2002
Journal: Endocrinology
Title: Double mutations in klotho and osteoprotegerin gene loci rescued osteopetrotic phenotype.
Volume: 143
Issue: 12
Pages: 4711-7
•
•
•
•
•
Publication
24327965 | J:221302
First Author: Lacombe J
Year: 2013
Journal: Mol Metab
Title: In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice.
Volume: 2
Issue: 4
Pages: 498-504
•
•
•
•
•
Publication
27460899 | J:241406
First Author: Piemontese M
Year: 2016
Journal: Am J Physiol Endocrinol Metab
Title: Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
Volume: 311
Issue: 3
Pages: E587-93
•
•
•
•
•
Publication
21750093 | J:191705
First Author: Xie H
Year: 2011
Journal: Cardiovasc Res
Title: Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression.
Volume: 92
Issue: 2
Pages: 296-306
•
•
•
•
•
Publication
21466864 | J:172507
First Author: Liang QQ
Year: 2011
Journal: Bone
Title: The expression of osteoprotegerin is required for maintaining the intervertebral disc endplate of aged mice.
Volume: 48
Issue: 6
Pages: 1362-9
•
•
•
•
•
Publication
16424941 | J:105417
First Author: Takasu H
Year: 2006
Journal: J Clin Invest
Title: c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
Volume: 116
Issue: 2
Pages: 528-35
•
•
•
•
•
Publication
19819969 | J:158217
First Author: Ota N
Year: 2009
Journal: Endocrinology
Title: Accelerated cartilage resorption by chondroclasts during bone fracture healing in osteoprotegerin-deficient mice.
Volume: 150
Issue: 11
Pages: 4823-34
•
•
•
•
•
Publication
26254339 | J:335281
First Author: McCarthy NI
Year: 2015
Journal: J Immunol
Title: Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development.
Volume: 195
Issue: 6
Pages: 2675-82
•
•
•
•
•
Publication
32614927 | J:291386
First Author: Bumdelger B
Year: 2020
Journal: PLoS One
Title: Disruption of Osteoprotegerin has complex effects on medial destruction and adventitial fibrosis during mouse abdominal aortic aneurysm formation.
Volume: 15
Issue: 7
Pages: e0235553
•
•
•
•
•
Publication
26825553 | J:252569
First Author: Hao Y
Year: 2016
Journal: Cardiovasc Res
Title: Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene.
Volume: 110
Issue: 1
Pages: 62-72
•
•
•
•
•
Publication
33633362 | J:303856
First Author: Nishida D
Year: 2021
Journal: Sci Rep
Title: RANKL/OPG ratio regulates odontoclastogenesis in damaged dental pulp.
Volume: 11
Issue: 1
Pages: 4575
•
•
•
•
•
Publication
23607938 | J:197898
 
First Author: Kao SY
Year: 2013
Journal: Neurobiol Dis
Title: Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss.
Volume: 56
Pages: 25-33
•
•
•
•
•
Publication
31729368 | J:281356
First Author: Arnold ND
Year: 2019
Journal: Nat Commun
Title: A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension.
Volume: 10
Issue: 1
Pages: 5183
•
•
•
•
•
Publication
23990207 | J:222218
First Author: Callegari A
Year: 2013
Journal: Arterioscler Thromb Vasc Biol
Title: Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification.
Volume: 33
Issue: 11
Pages: 2491-500
•
•
•
•
•
Publication
17148684 | J:116226
First Author: Secchiero P
Year: 2006
Journal: Am J Pathol
Title: An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction.
Volume: 169
Issue: 6
Pages: 2236-44
•
•
•
•
•
Publication
16840715 | J:128053
First Author: Bennett BJ
Year: 2006
Journal: Arterioscler Thromb Vasc Biol
Title: Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.
Volume: 26
Issue: 9
Pages: 2117-24
•
•
•
•
•
Publication
14500574 | J:87245
First Author: Nakamura M
Year: 2003
Journal: Endocrinology
Title: Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.
Volume: 144
Issue: 12
Pages: 5441-9
•
•
•
•
•
Publication
14977979 | J:88583
First Author: Okahashi N
Year: 2004
Journal: Infect Immun
Title: Porphyromonas gingivalis induces receptor activator of NF-kappaB ligand expression in osteoblasts through the activator protein 1 pathway.
Volume: 72
Issue: 3
Pages: 1706-14
•
•
•
•
•
Publication
27697839 | J:237353
First Author: Li M
Year: 2016
Journal: J Biol Chem
Title: Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis.
Volume: 291
Issue: 46
Pages: 24160-24171
•
•
•
•
•
Publication
32694652 | J:303162
First Author: Velletri T
Year: 2021
Journal: Cell Death Differ
Title: Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin.
Volume: 28
Issue: 1
Pages: 156-169
•
•
•
•
•
Publication
23039992 | J:245306
First Author: Nelson CA
Year: 2012
Journal: Structure
Title: RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor.
Volume: 20
Issue: 11
Pages: 1971-82
•
•
•
•
•
Publication
29415886 | J:297359
 
First Author: Nozawa S
Year: 2018
Journal: JCI Insight
Title: Osteoblastic heparan sulfate regulates osteoprotegerin function and bone mass.
Volume: 3
Issue: 3
•
•
•
•
•
Publication
12697767 | J:84114
First Author: Enomoto H
Year: 2003
Journal: J Biol Chem
Title: Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.
Volume: 278
Issue: 26
Pages: 23971-7
•
•
•
•
•
Publication
19633200 | J:153849
First Author: Sauer AV
Year: 2009
Journal: Blood
Title: ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency.
Volume: 114
Issue: 15
Pages: 3216-26
•
•
•
•
•
Publication
16951341 | J:138051
First Author: Maruyama K
Year: 2006
Journal: J Immunol
Title: Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice.
Volume: 177
Issue: 6
Pages: 3799-805
•
•
•
•
•
Publication
26923114 | J:234828
 
First Author: Lin J
Year: 2016
Journal: Nat Commun
Title: Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus.
Volume: 7
Pages: 10562
•
•
•
•
•
Publication
26783750 | J:249073
First Author: Bumdelger B
Year: 2016
Journal: PLoS One
Title: Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms.
Volume: 11
Issue: 1
Pages: e0147088
•
•
•
•
•
Publication
24847069 | J:211351
First Author: Shimamura M
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice.
Volume: 111
Issue: 22
Pages: 8191-6
•
•
•
•
•
Publication
32315212 | J:296824
First Author: Matsuo FS
Year: 2020
Journal: Am J Physiol Endocrinol Metab
Title: RANKL induces beige adipocyte differentiation in preadipocytes.
Volume: 318
Issue: 6
Pages: E866-E877
•
•
•
•
•
Publication
14981127 | J:88395
First Author: Ohazama A
Year: 2004
Journal: J Dent Res
Title: Opg, Rank, and Rankl in tooth development: co-ordination of odontogenesis and osteogenesis.
Volume: 83
Issue: 3
Pages: 241-4
•
•
•
•
•
Publication
29382610 | J:262318
 
First Author: Macari S
Year: 2018
Journal: Bone
Title: Lactation induces increases in the RANK/RANKL/OPG system in maxillary bone.
Volume: 110
Pages: 160-169
•
•
•
•
•
Publication
28070143 | J:274008
 
First Author: Toffoli B
Year: 2016
Journal: Mediators Inflamm
Title: Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System.
Volume: 2016
Pages: 6529728
•
•
•
•
•
Publication
32636266 | J:292206
First Author: Li M
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Antiresorptive activity of osteoprotegerin requires an intact heparan sulfate-binding site.
Volume: 117
Issue: 29
Pages: 17187-17194
•
•
•
•
•
Publication
22807088 | J:317377
First Author: Hinoi E
Year: 2012
Journal: J Bone Miner Res
Title: The transcription factor paired box-5 promotes osteoblastogenesis through direct induction of Osterix and Osteocalcin.
Volume: 27
Issue: 12
Pages: 2526-34
•
•
•
•
•
Publication
27064449 | J:235185
First Author: Luo J
Year: 2016
Journal: Nat Med
Title: LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption.
Volume: 22
Issue: 5
Pages: 539-46
•
•
•
•
•
Publication
26093292 | J:228675
First Author: Kobayashi Y
Year: 2015
Journal: Biochem Biophys Res Commun
Title: Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a.
Volume: 463
Issue: 4
Pages: 1278-83
•
•
•
•
•
Publication
29202462 | J:258336
First Author: Barrott JJ
Year: 2018
Journal: J Clin Invest
Title: Paracrine osteoprotegerin and β-catenin stabilization support synovial sarcomagenesis in periosteal cells.
Volume: 128
Issue: 1
Pages: 207-218
•
•
•
•
•
Publication
9837769 | J:51348
First Author: Gao YH
Year: 1998
Journal: Biochem Biophys Res Commun
Title: Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF).
Volume: 252
Issue: 3
Pages: 697-702
•
•
•
•
•
Publication
15564564 | J:104497
First Author: Collin-Osdoby P
Year: 2004
Journal: Circ Res
Title: Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.
Volume: 95
Issue: 11
Pages: 1046-57
•
•
•
•
•
Publication
21346198 | J:182985
First Author: Watkins M
Year: 2011
Journal: Mol Biol Cell
Title: Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling.
Volume: 22
Issue: 8
Pages: 1240-51
•
•
•
•
•
Publication
18172035 | J:145087
First Author: Morony S
Year: 2008
Journal: Circulation
Title: Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice.
Volume: 117
Issue: 3
Pages: 411-20
•
•
•
•
•
Publication
30626485 | J:291737
First Author: Gupta A
Year: 2019
Journal: Biochem Biophys Res Commun
Title: Connexin43 regulates osteoprotegerin expression via ERK1/2 -dependent recruitment of Sp1.
Volume: 509
Issue: 3
Pages: 728-733
•
•
•
•
•
Publication
17182555 | J:141939
First Author: Nakamichi Y
Year: 2007
Journal: J Immunol
Title: Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand derived from osteoblasts.
Volume: 178
Issue: 1
Pages: 192-200
•
•
•
•
•
Publication
25301844 | J:230464
First Author: Moran CS
Year: 2014
Journal: Arterioscler Thromb Vasc Biol
Title: Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse.
Volume: 34
Issue: 12
Pages: 2609-16
•
•
•
•
•
Publication
29662200 | J:271599
First Author: Weske S
Year: 2018
Journal: Nat Med
Title: Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss.
Volume: 24
Issue: 5
Pages: 667-678
•
•
•
•
•
Publication
23580147 | J:218869
First Author: Osako MK
Year: 2013
Journal: Arterioscler Thromb Vasc Biol
Title: Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification.
Volume: 33
Issue: 6
Pages: 1287-96
•
•
•
•
•
Publication
18242177 | J:131847
First Author: Lu W
Year: 2008
Journal: FEBS Lett
Title: R-spondin1 synergizes with Wnt3A in inducing osteoblast differentiation and osteoprotegerin expression.
Volume: 582
Issue: 5
Pages: 643-50
•
•
•
•
•
Publication
21439958 | J:171992
First Author: Ikeda K
Year: 2011
Journal: FEBS Lett
Title: Conditional expression of constitutively active estrogen receptor α in osteoblasts increases bone mineral density in mice.
Volume: 585
Issue: 9
Pages: 1303-9
•
•
•
•
•
Publication
23071670 | J:192089
First Author: Wang D
Year: 2012
Journal: PLoS One
Title: Accelerated calvarial healing in mice lacking Toll-like receptor 4.
Volume: 7
Issue: 10
Pages: e46945
•
•
•
•
•
Publication
23722907 | J:201429
First Author: Wiig H
Year: 2013
Journal: J Clin Invest
Title: Immune cells control skin lymphatic electrolyte homeostasis and blood pressure.
Volume: 123
Issue: 7
Pages: 2803-15
•
•
•
•
•
Publication
24948010 | J:230169
First Author: Isaac J
Year: 2014
Journal: Cell Death Differ
Title: DLX3 regulates bone mass by targeting genes supporting osteoblast differentiation and mineral homeostasis in vivo.
Volume: 21
Issue: 9
Pages: 1365-76
•
•
•
•
•
Publication
16251181 | J:107499
First Author: Palmqvist P
Year: 2006
Journal: J Biol Chem
Title: Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
Volume: 281
Issue: 5
Pages: 2414-29
•
•
•
•
•
Publication
25846796 | J:221580
First Author: Wu C
Year: 2015
Journal: Genes Dev
Title: Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin.
Volume: 29
Issue: 8
Pages: 817-31
•
•
•
•
•
Publication
36210025 | J:330577
 
First Author: Shin M
Year: 2022
Journal: Bone
Title: Mesenchymal cell TRPM7 expression is required for bone formation via the regulation of chondrogenesis.
Volume: 166
Pages: 116579
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom